A Phase II Sequential Dose-escalation Study Evaluating the Safety and Feasibility of Allogenlc Umbillcal Cord Derived Mesenchymal Stromal Cells for the Treatment of Adults w/ Treatment Refractory Lupus

Report on eligible participant enrollment at weekly intervals. Provide data to the Data Coordinating Center at regular intervals. Provide financial expenditure invoices/reports on a monthly basis and at other times when requested. Provide scientific progress reports as required by the prime grantee and the sponsor.